PCM
TMO icon

Peregrine Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Peregrine Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,811
Closed -$878K – 349
2025
Q3 		$878K Hold
1,811
– – 0.03% 261
2025
Q2 		$734K Buy
+1,811
New +$757K 0.02% 263
2020
Q4 		– Sell
-2,185
Closed -$965K – 384
2020
Q3 		$965K Buy
+2,185
New +$903K 0.03% 256

Other funds holding TMO

JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Peregrine Capital Management's TMO Position: Q4 2025 in Review

Peregrine Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 1,811 shares — an estimated $878K sold.

Peregrine Capital Management first reported a position in TMO in Q3 2020 and held it in 3 quarters. The position peaked at $965K in Q3 2020. 2,699 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Peregrine Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • Peregrine Capital Management sold 1,811 Thermo Fisher Scientific shares in Q4 2025, an estimated $878K.
  • Peregrine Capital Management first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 3 quarters.
  • Peregrine Capital Management's Thermo Fisher Scientific position peaked at $965K in Q3 2020.
  • 2,699 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Peregrine Capital Management's 13F filing for Q4 2025, filed 28 Jan 2026.